Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5786 | 1507 | 47.5 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
232 | 19686 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ESTROGEN RECEPTOR VARIANTS | Author keyword | 12 | 86% | 0% | 6 |
2 | JC HEUSON CANCEROL MAMMAIRE | Address | 10 | 42% | 1% | 19 |
3 | SERV HISTOL CYTOL EXPT | Address | 8 | 62% | 1% | 8 |
4 | TAMOXIFEN AZIRIDINE | Author keyword | 6 | 100% | 0% | 4 |
5 | ALFRED G KNUDSON CHAIR CANC | Address | 5 | 63% | 0% | 5 |
6 | SPLICE TARGETED PRIMERS | Author keyword | 4 | 75% | 0% | 3 |
7 | ANTIOESTROGEN RESISTANCE | Author keyword | 3 | 100% | 0% | 3 |
8 | SERV MEM 120 | Address | 3 | 100% | 0% | 3 |
9 | ESTROGEN RESPONSE ELEMENT | Author keyword | 3 | 18% | 1% | 15 |
10 | ESTROGEN RESPONSE ELEMENT ERE | Author keyword | 3 | 50% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN ESTROGEN RECEPTOR | 21 | 15% | 9% | 130 |
2 | LACKING EXON 4 | 21 | 85% | 1% | 11 |
3 | EXON 5 DELETION VARIANT | 20 | 100% | 1% | 9 |
4 | MCF 7 TUMOR VARIANT | 19 | 80% | 1% | 12 |
5 | MENINGIOMA TISSUE | 17 | 100% | 1% | 8 |
6 | ESTRADIOL INDUCED PHOSPHORYLATION | 15 | 68% | 1% | 13 |
7 | TAMOXIFEN STIMULATED GROWTH | 14 | 44% | 2% | 24 |
8 | ICI 164 384 | 13 | 50% | 1% | 19 |
9 | A B REGION | 12 | 86% | 0% | 6 |
10 | PROTEASOME MEDIATED PROTEOLYSIS | 9 | 64% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer | 2015 | 5 | 150 | 46% |
Estrogen receptor (ER) alpha mutations in breast cancer: hidden in plain sight | 2014 | 9 | 54 | 59% |
Estrogen receptor mutations in human disease | 2004 | 190 | 387 | 46% |
Estrogen receptor phosphorylation | 2003 | 247 | 116 | 43% |
Clinical significance of estrogen receptor phosphorylation | 2011 | 42 | 115 | 46% |
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors | 2011 | 50 | 262 | 39% |
Minireview: genomic organization of the human ER alpha gene promoter region | 2001 | 155 | 57 | 65% |
Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy | 2014 | 17 | 178 | 26% |
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS | 1994 | 2224 | 216 | 16% |
Estrogen receptor variants and mutations | 1997 | 75 | 70 | 79% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JC HEUSON CANCEROL MAMMAIRE | 10 | 42% | 1.3% | 19 |
2 | SERV HISTOL CYTOL EXPT | 8 | 62% | 0.5% | 8 |
3 | ALFRED G KNUDSON CHAIR CANC | 5 | 63% | 0.3% | 5 |
4 | SERV MEM 120 | 3 | 100% | 0.2% | 3 |
5 | EQUIPE ENDOCRINOL MOL REPROD | 2 | 29% | 0.5% | 7 |
6 | GLOBAL EDUC | 2 | 36% | 0.3% | 5 |
7 | HORMONE ASSOCIATED CANC GRP | 2 | 67% | 0.1% | 2 |
8 | REGULATORY EPIGEN DIS | 2 | 67% | 0.1% | 2 |
9 | MED DENT ENVIRONM MED | 2 | 50% | 0.2% | 3 |
10 | 407 S GOODWIN AVE | 2 | 40% | 0.3% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000295772 | ESTROGEN RECEPTOR BETA//ER BETA//RECEPTOR BIOL SECT |
2 | 0.0000202678 | SERAMS//MATH CHEM//ESTROGEN RECEPTOR LIGANDS |
3 | 0.0000177977 | AIB1//STEROID HORMONES SECT//RIP140 |
4 | 0.0000163599 | ESTROGEN RECEPTOR ALPHA GENE ESR1//ESTROGEN RECEPTOR POLYMORPHISMS//ESTROGEN RECEPTOR 1 |
5 | 0.0000159602 | AEBS//ANTIESTROGEN BINDING SITES//ANALOG II |
6 | 0.0000152362 | PROGESTERONE RECEPTOR ISOFORMS//PROGINS//PROGESTERONE RECEPTOR A |
7 | 0.0000144007 | ESTROGEN RECEPTOR ACTIVATION FACTOR//NUCLEAR ESTROGEN RECEPTOR II//NON ACTIVATED ESTROGEN RECEPTOR |
8 | 0.0000139798 | GPR30//GPER//PELP1 |
9 | 0.0000137851 | EP45//BIOMED SCI PATHOL BIOCHEM//APOVLDL II GENE |
10 | 0.0000096409 | AROMATASE INHIBITORS//EXEMESTANE//ANASTROZOLE |